Amarantus BioScience Holdings, Inc. (AMBS)

OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 24, 2026
-99.00%
Market Cap 630.00
Revenue (ttm) n/a
Net Income (ttm) -7.94M
Shares Out 630.41M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,237
Average Volume 168,112
Open 0.0000
Previous Close 0.0000
Day's Range 0.0000 - 0.0000
52-Week Range n/a
Beta -41.00
RSI 47.32
Earnings Date n/a

About AMBS

Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company’s diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer’s disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple sclerosis. Its therapeutic products in development comprise Eltoprazine, a sma... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 12
Stock Exchange OTCMKTS
Ticker Symbol AMBS
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.